Search

everythinglearnresearchcommunity

for

Search:↓

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

PCOS may be influenced by factors in the blood, not just the ovaries.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Adrenal androgens are important for puberty and are influenced by genetics.

Adrenal tumors in hamsters are rare and hard to diagnose, highlighting the need for better diagnostic tools.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

New genes and pathways are important for testosterone production and male sexual development.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Hirsutism and androgenetic alopecia in women are often due to increased androgen effects, and antiandrogen treatment is recommended to prevent further issues.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

CAH requires a multidisciplinary approach, and while current treatments help, future therapies show promise.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.